that (i) ara-A is not an absolute chain terminator of HSV-1 DNA synthesis, and (ii) the amount of ara-A incorporated into viral DNA is less than the amount incorporated into cellular DNA.
INTRODUCTION
The nucleoside analog, 9-&D-arabinofuranosyladenine (ara-A) is currently considered to be the drug of choice for the treatment of infections caused by herpes simplex virus type 1 (HSV-1). The drug is effective when applied ophthalmically for herpes simplex keratitis (Pavan-Langston et al., 1975) et al., 1977) . Results reported by several laboratories demonstrate that ara-A acts selectively against virus-infected cells; in viva the drug lacks toxicity in its antiviral dose range (Kurtz, 1975; Sloan, 1975) , and in vitro it exhibits little or no cytotoxicity at drug concentrations which inhibit viral replication (Shannon, 1975) . Previous studies in our laboratory have demonstrated that ara-A is a selective inhibitor of viral DNA synthesis in HSVinfected cells Schwartz et al., 1976) . The biochemical basis for this selectivity is poorly understood.
One proposed model for the selective antiviral mechanism of action of ara-A involves incorporation of the corresponding arabinosyl nucleotide into replicating DNA such that further DNA synthesis is inhibited.
Results published by Muller and co-workers (1977a) indicate that the majority of ara-A incorporated into replicating HSV DNA is present at 3'-hydroxyl termini, thereby suggesting that ara-A acts as a chain terminator of viral DNA synthesis. This observation, along with the fact that incorporation of ara-A into mammalian cell DNA is known to occur internally via internucleotide linkage (Plunkett and Cohen, 1975; Miiller et al., 1975) , led Miiller to suggest that the selective inhibition of HSV DNA synthesis by ara-A was due to the two different modes of incorporation of the drug into DNA (Miiller et al., 1977a, b) . That is, ara-A acts as a chain terminating nucleoside in HSV DNA, but not in mammalian DNA.
In the current study, we have reexamined the question of whether ara-A acts as a chain terminator of HSV DNA synthesis. The source of cells, the routine growth and passage of BHK 21/4 cells and KB cells, the techniques used for the enumeration of cells, the determination of cell viability, and the detection of mycoplasma contamination have been described previously Schwartz (1975) . After a l-h incubation at 3'7", the stock solution was decanted and any detached cells were removed by low-speed centrifugation.
The medium was then diluted and used in experiments requiring the presence of [3H]ara-A. By using this method, the level of [3H]adenine could be reduced from l-2% to less than 0.5%.
Virus. The HF strain of HSV type 1 (Flanagan, 1967) was obtained from Gary H. Cohen, University of Pennsylvania. The HSV cloning procedure developed by Klein (1975) was employed to prepare a clonal virus isolate. Subsequent passaging of this cloned isolate at low multiplicity (m.o.i. = 0.01) was carried out in KB cells to prepare virus stocks of high titer (lo*-109 PFU/ml).
The propagation and titration of HSV-1 were as described previously . HEPES pH = 7.4 at 22'), and supplemented with 10% calf serum.] The virus was allowed to adsorb for 1 hr at 37", then each monolayer was rinsed twice with warm VGM without serum. VGM containing 0, 0.1, 1.0, or 3.2 &I! r3H]ara-A was added to the monolayers and the flasks were incubated for an additional 18 hr. Pentostatin (1 pg/ml) was included in the drug-containing medium to prevent deamination of ara-A to arabinosylhypoxanthine (ara-H). After 18 hr, the cells were detached by vigorously shaking the flasks. The harvested cells were pelleted by centrifugation at 100 g for 15 min, and each pellet was resuspended in TES buffer. Pronase and sarkosyl were added to the cell suspensions at final concentrations of 2 mg/ml and 0.5%, respectively. The cell lysates were digested for 2 hr at 37", then mixed with cesium chloride in TES (final refractive index = 1.3996). Viral and cellular DNAs were separated by isopycnic density gradient centrifugation in a Ti60 rotor for 65 hr at 100,000 g. Each gradient was fractionated and the fractions containing HSV-1 DNA were pooled and recentrifuged in a second CSCl gradient to further purify the viral DNA. We estimate that contamination of viral DNA by cellular DNA was ~3%. Fractions containing viral DNA were pooled and dialyzed at 4" against 1 mM Tris buffer, pH 8.6. Viral DNA was purified from mature virions as follows. Monolayer cultures of KB cells were grown in plastic roller bottles to 80% confluency, at which time the cultures were infected with HSV-1 (m.o.i. = 5). After a l-hr incubation period at 37", unadsorbed virus was removed by rinsing the cell sheet twice with warm medium. Seventy milliliters of VGM supplemented with 10% calf serum plus [3H]ara-A and pentostatin (1 Fg/ml) was added to each 490 cm2 roller bottle. The roller bottles were incubated for 36 hr to permit maximum production of supernatant virus. Roller bottles were shaken to detach cells, and the infected cells were pelleted by centrifugation at 5000 rpm for 10 min in a Beckman J-21 preparative centrifuge to remove cells and cell debris. The supernatant fluid was then centrifuged at 15,000 rpm for 20 min at 4" in the J-21 centrifuge to pellet mature virions. The virus pellet was resuspended in 0.9 ml lysing buffer (0.1 !I4 NaCl, 0.1 IM HEPES, 0.02 M EDTA, pH 7.4), to which was added 100 ~120% sarkosyl, 50 ~1 10% sodium dodecyl sulfate, and 50 ,ug ribonuclease A per milliliter. The viral lysate was digested for 1 hr at 37", after which time 25 ~1 proteinase K (10 mg/ml stock preparation) was added and the lysate digested for 2 hr at 55". The digest was then added to TES buffer containing cesium chloride at a final refractive index of 1.3996 and centrifugation was carried out in a Ti60 rotor at 15" for 65 hr at 100,000 g. 'Those fractions containing the viral DNA pe;ak were pooled, PELLING, DRACH. AND SHIPMAN and dialyzed at 4" against three changes of 1 mM Tris, pH 8.6. The specific activities of viral DNA preparations were computed by determining the amounts of radioactivity and of DNA in aliquots of interest. Counts per minute were determined in a Beckman LS8100-Texas Instruments 733ASR liquid scintillation spectrometer system. Disintegrations per minute were calculated by means of a computer program (SUPERLIQ; Schwartz, 19'75) according to the Compton edge method described by Horrocks (1974) . The DNA content of companion aliquots was determined using a modification of the diphenylamine assay developed by Burton (1968) .
Cellular DNA which had been labeled with [3H]ara-A was purified from uninfected KB cells grown in suspension cultures. Briefly, KB cells from a log-phase suspension culture were used to seed four loo-ml spinner flasks at a cell density of 3 x lo" cells/ml. The suspension cultures were allowed to equilibrate for 1 hr. Following equilibration, 5.0 ml of medium supplemented with [3H]ara-A and pentostatin (1 pgiml) was added to each culture to yield final concentrations of 0, 0.1, 1.0, or 3.2 llJM [3H]-ara-A in a volume of 60 ml. At the time of drug addition and 18 hr later, aliquots (0.5 ml) were removed from the spinner flasks and pipetted into an equal volume of ice-cold HBS for use in determining the specific activity of the KB cell DNA. Cells were pelleted at 300 g for 10 min at 4", the medium was decanted, and the samples were stored at -20" for the diphenylamine assay and radioactivity determinations.
The amount of label incorporated into cell DNA was determined as follows. The pelleted cells from 0.5-ml aliquots were thawed and resuspended in 0.8 ml lysing buffer. The cells were lysed with 100 ~1 of 20% sarkosyl and 50 ~1 of sodium dodecyl sulfate (10%). Ribonuclease A was added to a final concentration of 50 pglml and the mixture was incubated at 37" for 1 hr. Twenty-five microliters of proteinase K (10 mg/ml) was added and the cell lysate was digested for 2 hr at 55". Fifty-microliter samples were spotted onto filter papers and washed three times in ice-cold 5% trichloroacetic acid, twice in ethanol, and once in diethyl ether. The filter papers were counted in a liquid scintillation spectrometer using a toluene-based cocktail containing 3% Protosol and 0.4% Omnifluor (New England Nuclear, Boston, Mass.). The DNA content of KB cells from suspension cultures was determined using a modification of the diphenylamine assay. On the day of the assay, the washed, frozen 0.5-ml cell pellets were thawed and 1.0 ml of 1 N HClO, was added to each tube. Samples were vortexed to resuspend the cell pellets, and the diphenylamine assay procedure was carried out as described previously for purified dialyzed DNA.
Enzymatic digestion and chromatographic analysis of DNA. Purified viral and cellular DNA were enzymatically digested to 3'-mononucleotides and terminal nucleosides with micrococcal nuclease and spleen phosphodiesterase using a modification of techniques published by Josse and co-workers (1961) and Muller and others (1975) . Five to ten micrograms of DNA in a 200-~1 volume were digested with 0.6 pg micrococcal nuclease (14,000 unitsimg) in 1 mil4 Tris, pH 8.6, supplemented with 1 ~1 of pentostatin (1 mgiml) and 10 ~1 of 0.1 M CaCl,. The pH of the digestion mixture was adjusted to 9.5 with 0.1 N NaOH. After a 2-hr incubation period at 37", the mixture was further digested for three 1-hr periods at 37" with 15 pg of spleen phosphodiesterase in consecutive additions, pH 7.0. EDTA (final concentration of 1 mM) was added to inhibit phosphatases which were present as contaminants in the phosphodiesterase preparation. The pH was adjusted to 6.5-7.0 with 1 N HCl. The digested DNA was resolved into mononucleotides and nucleosides by means of thin-layer chromatography on silica gel plates (Analtech, Inc., Newark, Del.) as previously described (Schwartz and Drach, 1978) .
Viral DNA also was digested to 5'-mononucleotides by sequential enzymatic hydrolysis with DNase I and snake venom phosphodiesterase (Plunkett and Cohen, 1975) . Samples of DNA (200 ~1) were added to tubes containing 25 ~1 of 0.1 M MgC&, and 25 ~1 DNase I (200 units) in 1 mM Tris, pH 7.0. Pentostatin was added to a final concentration of 1 pg/ml. The pH was adjusted to 7.8 and the digestion mixture was incubated for 2 hr at 37". Snake venom phosphodiesterase was added (0.1 mg in 65 ~1 m&f Tris, pH 8.8) and the pH was adjusted to 8.8 with 0.1 N sodium hydroxide. After an incubation period of 2-3 hr at 37", the digest was precipitated with 2 vol of absolute ethanol at -2o", and samples were analyzed by two-dimensional thin-layer chromatography on polyethyleneimine (PEI)-cellulose plates, as detailed previously (Schwartz and Drach, 1978) . Plates were sectioned into counting vials and each section was extracted with 2 ml of 0.1 N HCl in methanol for 1 hr or more at room temperature. Scintillation cocktail was added and samples were counted to determine the number of disintegrations per minute associated with each nucleotide.
When necessary, viral or cellular DNA, previously digested to mononucleotides, was further digested to nucleosides by alkaline phosphatase treatment (Miiller et al., 1975) . Aliquots (100 ~1) of digested DNA were treated with 0.55 unit of bovine alkaline phosphatase (0.1 unit/mg) for 16 hr at 37". Pentostatin was added to a concentration of 1 pglml. The pH of the enzymatic reaction was adjusted to 9.0 with 0.1 N sodium hydroxide. After digestion, samples were analyzed by thin-layer chromatography on silica gel plates, as described previously (Schwartz and Drach, 1978) .
Restriction endonuclease analysis of HSV DNA. HSV-1 DNA, isolated from purified mature virions, was digested with the restriction endonuclease Hind111 and subjected to electrophoresis through 0.6% agarose tube gels using a procedure published by Wagner and co-workers (Stringer et al., 1978) . After electrophoresis, gels were sliced into l-mm sections using a semiautomatic gel slicer designed by Mr. Josef Biela, Mechanical Instrumentation Shop, Division of Biological Sciences, University of California at Irvine, Irvine, California. Each gel slice was placed in a glass scintillaation counting vial, and the agarose was hydrolyzed in 0.5 ml of 10% perchloric acid by heating for 3 min at 78". A lo-ml aliquot In order to determine if ara-A is incorporated into HSV-1 DNA, viral DNA was isolated from lysates of infected KB cells which had been incubated in the presence of [3H]ara-A. Figure 1 illustrates the separation of viral and cellular DNA and shows the effects of increasing concentrations of ara-A (and consequently, the amount of radioactive label) in the cell culture medium. At 0.1 $I4 r3H]ara-A (upper panel, the concentration of radioactive isotope was low (1.1 &i/ml), resulting in little labeling of viral and cellular DNA. At 1.0 fl L3H]ara-A (11.1 &X/ml) (middle 'I 2 &i of [3H]ara-AMP in 200 ~1 of 1 m&f Tris (pH 7.0) were incubated at 37" for 3 hr with 0.045 mg spleen phosphodiesterase (Worthington Biochemical Corp.). EDTA was added prior to incubation to yield the final concentrations indicated above. Following incubation, 4 ~1 of each mixture was chromatographed on silica gel plates as described under Materials and Methods. The plates were fractionated and the percentage of radioactivity associated with the dephosphorylated ara-A fraction was determined with a scintillation spectrometer. panel), increased incorporation of isotope was seen in both viral and cellular DNA. The antiviral activity of 1.0 $I4 ara-A is minimal at this concentration (Schwartz et al., 1976) , and little preferential inhibition of viral DNA was observed. The highest concentration of ["Hlara-A used, 3.2 r-JM or 35.6 pCi/ml (lower panel), is close to the 50% inhibitory concentration of the drug (Schwartz et al., 1976) , and resulted in a selective decrease in the peak size of viral DNA compared to cellular DNA. Cesium chloride gradient fractions corresponding to the viral DNA peaks were pooled, centrifuged again in CsCl density gradients to further purify the viral DNA, and subjected to enzymatic digestion with micrococcal nuclease and spleen phosphodiesterase.
Early experiments which used micrococcal nuclease and spleen phosphodiesterase to digest t3H]ara-A-labeled DNA suggested that one or both of the enzymes contained contaminating phosphatases which dephosphorylated nucleoside 3'-monophosphates to the corresponding nucleosides. Subsequent tests were carried out in which r3H]ara-AMP was exposed to micrococcal nuclease or spleen phosphodiesterase and the amount of [3H]ara-A produced was monitored by thin-layer chromatography on silica gel plates. These experiments demonstrated that the micrococcal nuclease was free of phosphatases(s), but that the spleen phosphodiesterase preparation contained considerable phosphatase activity (data not shown). Because phosphatases are inhibited by EDTA whereas phosphodiesterase is activated (Hilmoe, 1960) , EDTA was included in the enzymatic digestion mixture. Table 1 presents the results of an experiment carried out to determine the optimal concentration of EDTA. When no EDTA was included, 13% of the ["Hlara-AMP in the incubation mixture was dephosphorylated to ara-A by contaminating phosphatase(s) in the spleen phosphodiesterase.
Addition of as little as 1 $l4 EDTA effectively inhibited the phosphatase activity. A concentration of 1 m&f was chosen as an appropriate level of EDTA for use in the DNA digestion mixtures.
This concentration inhibited contaminating phosphatase activity without affecting the activity of spleen phosphodiesterase (data not shown).
Using 1 m&Z EDTA in appropriate digestion mixtures, the purified viral DNA labeled with [:'H]ara-A was now enzymatitally cleaved with micrococcal nuclease and spleen phosphodiesterase.
The resulting DNA digests were resolved into S'-mononucleotides and nucleosides by means of silica gel thin-layer chromatography. Figure 2 (upper panel) is a representative profile of the distribution of radioactivity on a silica gel plate used to chromatograph a sample of digested viral DNA labeled with 1.0 fl ["H]ara-A. Over 95% of the tritium label was detected at the origin where nucleotides would remain. Similar profiles were obtained when viral DNA isolated from cells incubated with 0.1 and 3.2 $I4 ["H]ara-A were digested and chromatographed (data not shown). Only 0.5-2.0% of the counts were detected in the ara-A fraction at each drug concentration. In a control experiment using digested DNA labeled with ["Hlthymidine, 1.5% of the radioactivity on the silica gel plate migrated with the nucleoside thymidine. The close correspondence of these two percentage values indicates that the radioactivity associated with the ara-A fraction in Fig. 2 (upper panel) represents the contribution from strands of DNA which happen to have 3'-terminal ara-A moieties at the time of DNA isolation or from random nicking during DNA purification. It appears, therefore, that ara-A was incorporated internally into viral DNA via internucleotide linkage and was not acting as an absolute chain terminator.
To verify that the radioactivity at the origin on the silica gel chromatogram shown in Fig. 2 (upper panel) was from arabinosyl nucleotides, labeled material was further digested to nucleosides with alkaline phosphatase and chromatographed on silica gel plates. The chromatographie distribution of radioactivity of a representative alkaline phosphatase digest is illustrated in Fig. 2 (lower panel) . Similar profiles were obtained when viral DNA labeled with 0.1 or 3.2 $l4 ["Hlara-A was digested and chromatographed (data not shown). As can be seen in the figure, nearly all of the radioactivity was associated with ara-A and not with ribosyl, deoxyribosyl, or other arabinosyl nucleosides. The small percentage of counts present in fraction "6" uith the deoxyadenosine standard presumably originated from the 0.6% [:'H]adenine contaminant in the commercial preparation of ["Hlara-A.
Having established that ara-A was internally incorporated into HSV-1 DNA from infected KB cell lysates, further analysis was performed to determine whether the amount of ara-A incorporated into viral DNA increased as the concentration of ara-A in the external medium was increased. The specific activities of samples of viral DNA, purified previously from cells infected with HSV-1 and labeled with L3H]ara-A, were determined as described under Materials and Methods. The number of ara-AMP molecules incorporated per 10,000 molecules of deoxyadenosine monophosphate at each drug level was then computed using the formula shown in footnote b in activities of the ["Hlara-A-labeled viral DNA and the corresponding number of ara-AMP residues incorporated at each drug concentration are presented in Table  2 . From these values it is evident that the number of ara-AMF' molecules incorporated into viral DNA increased as the concentration of ara-A in the external medium was increased. Fig. 2 ).
h arabinosyl nucleotide is never packaged into progeny virions. To test this possibility, we have analyzed HSV-1 DNA isolated from mature enveloped virions. Virus particles were isolated from the supernatant fluid of HSV-l-infected KB cell monolayer cultures which had been incubated in the presence of 1.0 fl r3H]-ara-A. This concentration of [3H]ara-A was selected to permit a high level of radioactivity in the external medium (11.1 @Z/ml) with minimal inhibition of viral DNA synthesis (see Fig. 1, middle panel) . Viral DNA was extracted from supernatant virions and purified by centrifugation in CsCl isopycnic density gradients, as described under Materials and Methods. A typical profile from a CsCl gradient is shown in the inset to Fig. 3 . A prominent peak of viral DNA (fractions 16-26) and a small peak of cellular DNA (fractions 27-29) can be seen. Only fractions 18-22 of the viral DNA peak (shaded area) were pooled, in order to prevent contamination by KB cell DNA. The purified DNA was digested with micrococcal nuclease and spleen phosphodiesterase, followed by separation of nucleotides and nucleosides on silica gel thin-layer chromatograms.
The distribution of total dpm on the fractionated plate is illustrated in Fig. 3 (upper panel) . Ninety-seven percent of the disintegrations per minute remained at the origin as nucleoside monophosphates and only 2% of the counts migrated with the unlabeled ara-A standard. Thus, it appears that viral DNA containing incorporated ara-A had been packaged into virions with subsequent release of the mature virions into the surrounding supernatant medium. To verify that the radioactivity observed at the origin of the silica gel plate was arabinosyl and not ribosyl or deoxyribosyl nucleotides, the nuclease-treated DNA was digested further with alkaline phosphatase as described previously. Figure 3 (lower panel) illustrates that nearly all of the radioactivity was associated with the unlabeled ara-A standard when chromatographed on a silica gel plate. Thus, as was the case with viral DNA isolated from infected cell lysates, it appears that ara-A was internally incorporated into viral DNA via internucleotide linkage and was not acting as an absolute chain terminator.
Confirmation of the a'bove results was obtained by digesting DNA from mature virions to 5'-nucleotides and characterizing the nucleotides by thin-layer chromatography. Viral DNA isolated from whole virions (as depicted in the inset to Fig. 3 ) was digested with DNase 1 and snake venom phosphodiesterase. The resulting 5'-mononucleotides were separated by twodimensional thin-layer chromatography on polyethyleneimine (PEI)--cellulose plates. Figure 4 shows the separation of unlabeled arabinosyl, deoxyribosyl, and ribosyl mono-, di-, and triphosphate standards visualized under ultraviolet light. The number of disintegrations per minute associated with the monophosphates of ara-A, deoxyadenosine, and ara-H are indicated; less than 10 dpm were associated with all other nucleotides. The observation that approximately 90% of the total radioactivity on the PEI plate was associated with ara-AMP supports the results obtained with the micrococcal nuclease-spleen The pattern of incorporation of ara-A into the HSV-1 genome was examined to determine whether ara-A was preferentially incorporated into specific sites. HSV-1 DNA previously labeled with 1.0 PM ["Hlara-A was isolated from mature virions (as depicted in the inset to Fig. 3 ) and digested with the restriction endonuclease HindIII. After separation of the viral DNA fragments by electrophoresis in 0.6% agarose, the cylindrical gels were sliced and the amount of radioactivity in each slice was determined in a scintillation spectrometer. ara-AMP molecules incorporated per 10,000 dAMP molecules at each of the three drug levels. As can be seen from this table, the specific activities and hence, the amount of incorporated r3H]ara-AMP increased as the concentration of [3H]ara-A in the external medium was increased. Although the uptake of [3H]ara-A into both cellular and viral DNA was linear as a function of drug concentration (see Discussion), the number of ara-AMP molecules incorporated per 10,000 dAMP residues was 1.8-to 5.8-fold higher in cellular DNA when compared with viral DNA.
DISCUSSION
Our ability to demonstrate internucleotide incorporation of ara-A into viral DNA has important implications with respect to the mechanism of action of ara-A. It has been hypothesized that ara-A may exert its selective inhibition of viral DNA synthesis in HSV-infected cells by acting as a chain terminator of DNA strand elongation in viral replication, yet be incorporated internally through internucleotide linkage in replicating cell DNA (Muller et al., 1977a) . The experimental results presented in the present communication, however, are in opposition to those reported by Mtiller and his co-workers. In our hands, ara-A was incorporated internally as ara-AMP into HSV DNA via internucleotide linkage. The most plausible explanation for these differing results arises from the contaminating phosphatase activity we have shown to be present in some commercial preparations of spleen phosphodiesterase. This phosphatase activity, if left uninhibited during digestion of viral DNA containing incorporated ara-A, has the ability to convert any existing ara-AMP to ara-A. As a result, analysis of the digested DNA by thin-layer chromatography would indicate that a major portion of the incorporated label is present in nucleoside form, thereby resulting in the incorrect interpretation that ara-A is incorporated into replicating viral DNA strands as a chainterminating moiety. In our system, the use of 1 nUl4 EDTA in the digestion mixture inhibited the phosphatase activity while not affecting spleen phosphocliesterase. A less plausible explanation for the differing results is that Mtiller and co-workers performed their analysis on "heavy viral DNA" (Miiller et al., 1977a, b) , a species of DNA never observed by us. An even less satisfying explanation is that the differences are due to variability between virus strains and cell types.
Having demonstrated that ara-A was incorporated internally into HSV-1 DNA from infected-cell lysates, further studies were undertaken to determine whether this viral DNA could be packaged into newly made progeny virions. The question is important because it is possible that viral DNA containing ara-A is recognized as defective and is never packaged into mature virions. There is also the possibility that repair enzymes remove the incorporated ara-A from newly synthesized strands of viral DNA before packaging occurs.
In carrying out these studies, HSV-1 DNA was isolated from virions which had been purified from the supernatant fluid of infected KB cells incubated in the presence of r3H]ara-A. By means of enzymatic digestion and subsequent chromatography, the presence of incorporated r3H]ara-A in packaged viral DNA was demonstrated clearly. Verification of these results was obtained through the use of a second method of enzymatic digestion and two-dimensional chromatography.
As with HSV DNA isolated from infected-cell lysates, the ["HIara-A found in virion-associated DNA was shown to be incorporated internally via internucleotide linkage.
To determine whether preferential sites of ara-A incorporation exist, the pattern of incorporation of ara-A into the HSV-1 genome was examined. If ara-A were acting as a chain terminator, one would expect that incorporation of [3H]ara-A would be limited to restriction endonuclease fragments containing initiation sites. Because the number of initiation sites is limited (Roizman, 1979) , only a small number of fragments would be labeled. If ara-A were not acting as a chain terminator, incorporation of r3H]ara-A would be observed in all restriction fragments. Analysis of HindIII-digested HSV- (Manteuil et al., 1974) .
Although no difference was observed in the amounts of ara-A incorporated into areas of the genome delimited by the Hind111 cleavage, it is possible that significant variation did exist at a level below that detected by the studies described herein. The use of restriction enzymes which cut HSV DNA into smaller fragments might be employed to study incorporation of ara-A into genomic regions of interest. Furthermore, recent success with in vitro transcription and translation systems using HSV-1 DNA (Holland et al., 1980) may make it possible to study the effects of incorporated ara-A on the accuracy of transcription and resultant translation products.
Even though ara-A was not a chain terminator of viral DNA synthesis, internal incorporation of ara-A into DNA could be reponsible for the selective antiviral activity of the drug. Helical aberrations in DNA structure induced by the incorporation of an arabinosyl nucleoside (Provenzale and Nagyvary, 1970) could lead to errors in DNA transcription and replication. If incorporation of ara-A into DNA is critically involved in the mode of action of the drug, then one might expect more incorporation into viral DNA than into cellular DNA. To test this hypothesis, the amount of ara-A incorporated into viral and cellular DNA was determined at several drug concentrations. The data in Table 2 , however, illustrate that substantially more ara-A was incorporated into cellular DNA than into viral DNA. These results indicate that the amount of ara-A incorporated into DNA may not be the only factor operative in the ability of the drug to inhibit viral replication.
Internal incorporation of ara-A into cellular DNA already has been demonstrated by others (LePage, 1970; Plunkett and Cohen, 1975; Miiller et al., 1975) , but these reports did not measure the amount of incorporation as a function of varying drug concentrations in the external medium. An analysis of the data in Table 2 indicates that there is a linear relationship between the concentration of ara-A in the extracellular medium and the number of ara-AMP residues incorporated. Linear regression analysis yielded a slope of +8.12 and a coefficient of correlation of +l.OOO for viral DNA and a slope of +51.0 and a coefficient of correlation of +0.998 for cellular DNA demonstrating a more extensive incorporation into cellular DNA. Although the slopes are very different, they represent only the overall outcome of a very complex series of reactions. In actuality, the rates of uptake might be identical and the differences in slope could reflect undetected processes such as the selective removal of arabinosyl nucleotides from viral DNA. Such excision could be performed by the exonuclease associated with the herpes simplex virus DNA polymerase (Knopf, 1979) .
The findings in this paper have important implications with respect to the mechanism of action of ara-A. Although ara-A has been shown to selectively inhibit HSV-1 DNA synthesis at the drug concentrations used in these studies, our present data indicate that there is no apparent connection between this selective inhibition and the incorporation of ara-A into viral and cellular DNA. We conclude that the selective inhibition of HSV DNA replication cannot be attributed solely, if at all, to the internal incorporation of this fraudulent nucleoside into DNA.
